{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:27:21Z","timestamp":1787030841364,"version":"build-2736575974"},"reference-count":261,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"DOI":"10.1038\/s10038-026-01505-7","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:41:51Z","timestamp":1787020911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical significance of miRNAs and exosomal miRNAs in non-small cell lung cancer: diagnostic, prognostic, and therapeutic perspectives"],"prefix":"10.1038","author":[{"given":"Imteyaz Ahmad","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdish Prasad","family":"Meena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1505_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cllc.2023.10.007","volume":"25","author":"N Florez","year":"2024","unstructured":"Florez N, Kiel L, Riano I, Patel S, DeCarli K, Dhawan N, et al. Lung cancer in women: the past, present, and future. Clin Lung Cancer. 2024;25:1\u20138.","journal-title":"Clin Lung Cancer"},{"key":"1505_CR2","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1513\/pats.200809-100TH","volume":"5","author":"T Walser","year":"2008","unstructured":"Walser T, Cui X, Yanagawa J, Lee JM, Heinrich E, Lee G, et al. Smoking and lung cancer. Proc Am Thorac Soc. 2008;5:811\u20135.","journal-title":"Proc Am Thorac Soc"},{"key":"1505_CR3","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.21037\/tlcr.2019.03.05","volume":"8","author":"A Shankar","year":"2019","unstructured":"Shankar A, Dubey A, Saini D, Singh M, Prasad CP, Roy S, et al. Environmental and occupational determinants of lung cancer. Transl Lung Cancer Res. 2019;8:S31\u201349.","journal-title":"Transl Lung Cancer Res"},{"key":"1505_CR4","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1183\/13993003.00359-2016","volume":"48","author":"J Malhotra","year":"2016","unstructured":"Malhotra J, Malvezzi M, Negri E, La Vecchia C, Boffetta P. Risk factors for lung cancer worldwide. Eur Respir J. 2016;48:889\u2013902.","journal-title":"Eur Respir J"},{"key":"1505_CR5","first-page":"7","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7\u201333.","journal-title":"CA Cancer J Clin"},{"key":"1505_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","volume":"25","author":"V Relli","year":"2019","unstructured":"Relli V, Trerotola M, Guerra E, Alberti S. Abandoning the notion of non-small cell lung Cancer. Trends Mol Med. 2019;25:585\u201394.","journal-title":"Trends Mol Med"},{"key":"1505_CR7","unstructured":"Lung Cancer Survival Rates | 5-Year Survival Rates for Lung Cancer [Internet]. [cited 2025 Jan 16]. Available from: https:\/\/www.cancer.org\/cancer\/types\/lung-cancer\/detection-diagnosis-staging\/survival-rates.html."},{"key":"1505_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117473","volume":"248","author":"MMH Sohel","year":"2020","unstructured":"Sohel MMH. Circulating microRNAs as biomarkers in cancer diagnosis. Life Sci. 2020;248:117473.","journal-title":"Life Sci"},{"key":"1505_CR9","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/bs.acc.2017.10.003","volume":"83","author":"M Mac\u00edas","year":"2018","unstructured":"Mac\u00edas M, Alegre E, D\u00edaz-Lagares A, Pati\u00f1o A, P\u00e9rez-Gracia JL, Sanmamed M, et al. Liquid biopsy: from basic research to clinical practice. Adv Clin Chem. 2018;83:73\u2013119.","journal-title":"Adv Clin Chem"},{"key":"1505_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nrclinonc.2014.5","volume":"11","author":"H Schwarzenbach","year":"2014","unstructured":"Schwarzenbach H, Nishida N, Calin GA, Pantel K. Clinical relevance of circulating cell-free microRNAs in cancer. Nat Rev Clin Oncol. 2014;11:145\u201356.","journal-title":"Nat Rev Clin Oncol"},{"key":"1505_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mam.2018.07.003","volume":"70","author":"MA Iqbal","year":"2019","unstructured":"Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Asp Med. 2019;70:3\u201320.","journal-title":"Mol Asp Med"},{"key":"1505_CR12","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1101\/gad.1399806","volume":"20","author":"MA Valencia-Sanchez","year":"2006","unstructured":"Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev. 2006;20:515\u201324.","journal-title":"Genes Dev"},{"key":"1505_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","volume":"59","author":"JWF Catto","year":"2011","unstructured":"Catto JWF, Alcaraz A, Bjartell AS, De Vere White R, Evans CP, Fussel S, et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59:671\u201381.","journal-title":"Eur Urol"},{"key":"1505_CR14","doi-asserted-by":"publisher","first-page":"3865","DOI":"10.1093\/nar\/gkw116","volume":"44","author":"N Ludwig","year":"2016","unstructured":"Ludwig N, Leidinger P, Becker K, Backes C, Fehlmann T, Pallasch C, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44:3865\u201377.","journal-title":"Nucleic Acids Res"},{"key":"1505_CR15","doi-asserted-by":"publisher","first-page":"e260.","DOI":"10.1097\/MPA.0000000000002297","volume":"53","author":"N Singh","year":"2024","unstructured":"Singh N, Khan IA, Rashid S, Rashid S, Roy S, Kaushik K, et al. MicroRNA signatures for pancreatic cancer and chronic pancreatitis: expression profiling by NGS. Pancreas. 2024;53:e260.","journal-title":"Pancreas"},{"key":"1505_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155417","volume":"260","author":"IA Khan","year":"2024","unstructured":"Khan IA, Singh N, Gunjan D, Nayak B, Dash NR, Pal S, et al. Serum miR-215-5p, miR-192-5p and miR-378a-5p as novel diagnostic biomarkers for periampullary adenocarcinoma. Pathol - Res Pract. 2024;260:155417.","journal-title":"Pathol - Res Pract"},{"key":"1505_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3390\/genes15030338","volume":"15","author":"D Coleman","year":"2024","unstructured":"Coleman D, Kuwada S. miRNA as a biomarker for the early detection of colorectal cancer. Genes. 2024;15:338. https:\/\/doi.org\/10.3390\/genes15030338.","journal-title":"Genes"},{"key":"1505_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-022-00877-1","author":"IA Khan","year":"2022","unstructured":"Khan IA, Saraya A. Circulating MicroRNAs as noninvasive diagnostic and prognostic biomarkers in pancreatic cancer: a review. J Gastrointest Cancer. 2022. https:\/\/doi.org\/10.1007\/s12029-022-00877-1.","journal-title":"J Gastrointest Cancer"},{"key":"1505_CR19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/MOU.0000000000001137","volume":"34","author":"NT Tavares","year":"2024","unstructured":"Tavares NT, Lobo J, Bagrodia A. MicroRNAs for detecting occult genitourinary cancer. Curr Opin Urol. 2024;34:20\u20136.","journal-title":"Curr Opin Urol"},{"key":"1505_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"IA Khan","year":"2021","unstructured":"Khan IA, Rashid S, Singh N, Rashid S, Singh V, Gunjan D, et al. Panel of serum miRNAs as potential non-invasive biomarkers for pancreatic ductal adenocarcinoma. Sci Rep. 2021;11:1.","journal-title":"Sci Rep"},{"key":"1505_CR21","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/nature03702","volume":"435","author":"J Lu","year":"2005","unstructured":"Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834\u20138.","journal-title":"Nature"},{"key":"1505_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol. 2018;9:402.","journal-title":"Front Endocrinol"},{"key":"1505_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","volume":"13","author":"H Dana","year":"2017","unstructured":"Dana H, Chalbatani GM, Mahmoodzadeh H, Karimloo R, Rezaiean O, Moradzadeh A, et al. Molecular mechanisms and biological functions of siRNA. Int J Biomed Sci. 2017;13:48\u201357.","journal-title":"Int J Biomed Sci"},{"key":"1505_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9601876","volume":"2020","author":"WX Xue","year":"2020","unstructured":"Xue WX, Zhang MY, Rui Li, Liu X, Yin YH, Qu YQ. Serum miR-1228-3p and miR-181a-5p as noninvasive biomarkers for non-small cell lung cancer diagnosis and prognosis. Biomed Res Int. 2020;2020:9601876.","journal-title":"Biomed Res Int"},{"key":"1505_CR25","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/s41416-024-02831-3","volume":"131","author":"M Abdipourbozorgbaghi","year":"2024","unstructured":"Abdipourbozorgbaghi M, Vancura A, Radpour R, Haefliger S. Circulating miRNA panels as a novel non-invasive diagnostic, prognostic, and potential predictive biomarkers in non-small cell lung cancer (NSCLC). Br J Cancer. 2024;131:1350\u201362.","journal-title":"Br J Cancer"},{"key":"1505_CR26","doi-asserted-by":"crossref","unstructured":"Arab A, Karimipoor M, Irani S, Kiani A, Zeinali S, Tafsiri E, et al. Potential circulating miRNA signature for early detection of NSCLC. Cancer Genet. 2017;216\u20137:150\u20138.","DOI":"10.1016\/j.cancergen.2017.07.006"},{"key":"1505_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0149-3","volume":"15","author":"Q Geng","year":"2014","unstructured":"Geng Q, Fan T, Zhang B, Wang W, Xu Y, Hu H. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer. Respir Res. 2014;15:149.","journal-title":"Respir Res"},{"key":"1505_CR28","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3892\/ol.2016.5462","volume":"13","author":"H Zhang","year":"2017","unstructured":"Zhang H, Mao F, Shen T, Luo Q, Ding Z, Qian L, et al. Plasma miR-145, miR-20a, miR-21 and miR-223 as novel biomarkers for screening early-stage non-small cell lung cancer. Oncol Lett. 2017;13:669\u201376.","journal-title":"Oncol Lett"},{"key":"1505_CR29","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3389\/fonc.2020.00855","volume":"10","author":"W Wang","year":"2020","unstructured":"Wang W, Chen D, Chen W, Xin Z, Huang Z, Zhang X, et al. Early detection of non-small cell lung cancer by using a 12-microRNA panel and a nomogram for assistant diagnosis. Front Oncol. 2020;10:855.","journal-title":"Front Oncol"},{"key":"1505_CR30","first-page":"50","volume":"11","author":"Abdel","year":"2020","unstructured":"Abdel Ghany SM, Ali EM, Ahmed A, Hozayen WG, Mohamed-Hussein AA, et al. Circulating miRNA-30a and miRNA-221 as novel biomarkers for the early detection of non-small-cell lung cancer. Middle East J Cancer. 2020;11:50\u20138.","journal-title":"Middle East J Cancer"},{"key":"1505_CR31","doi-asserted-by":"crossref","unstructured":"X Z, J T, Y C, S M, W B, Y P, et al. Identification of serum MiRNAs as candidate biomarkers for non-small cell lung cancer diagnosis. BMC Pulmonary Med. 2022:16;22.","DOI":"10.1186\/s12890-022-02267-6"},{"key":"1505_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573399815666190115151500","volume":"8","author":"HF Hetta","year":"2019","unstructured":"Hetta HF, Zahran AM, Shafik EA, El-Mahdy RI, Mohamed NA, Nabil EE, et al. Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer. Microrna. 2019;8:206\u201315.","journal-title":"Microrna"},{"key":"1505_CR33","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.7002","volume":"7","author":"J Chen","year":"2019","unstructured":"Chen J, Wu L, Sun Y, Yin Q, Chen X, Liang S, et al. Mir-421 in plasma as a potential diagnostic biomarker for precancerous gastric lesions and early gastric cancer. PeerJ. 2019;7:e7002.","journal-title":"PeerJ"},{"key":"1505_CR34","doi-asserted-by":"publisher","first-page":"15350","DOI":"10.18632\/oncotarget.24601","volume":"9","author":"F Moshiri","year":"2018","unstructured":"Moshiri F, Salvi A, Gramantieri L, Sangiovanni A, Guerriero P, De Petro G, et al. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget. 2018;9:15350\u201364.","journal-title":"Oncotarget"},{"key":"1505_CR35","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/diagnostics11030425","volume":"11","author":"J Kryczka","year":"2021","unstructured":"Kryczka J, Migdalska-S\u0119k M, Kordiak J, Kisza\u0142kiewicz JM, Pastuszak-Lewandoska D, Antczak A, et al. Serum extracellular vesicle-derived miRNAs in patients with non-small cell lung cancer\u2014search for non-invasive diagnostic biomarkers. Diagnostics. 2021;11:425.","journal-title":"Diagnostics"},{"key":"1505_CR36","first-page":"118","volume":"8","author":"R Sheervalilou","year":"2019","unstructured":"Sheervalilou R, Lotfi H, Shirvaliloo M, Sharifi A, Nazemiyeh M, Zarghami N. Circulating MiR-10b, MiR-1 and MiR-30a expression profiles in lung cancer: possible correlation with clinico-pathologic characteristics and lung cancer detection. Int J Mol Cell Med. 2019;8:118\u201329.","journal-title":"Int J Mol Cell Med"},{"key":"1505_CR37","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3892\/ol.2021.13053","volume":"22","author":"HG Jiang","year":"2021","unstructured":"Jiang HG, Dai CH, Xu YP, Jiang Q, Xia XB, Shu Y, et al. Four plasma miRNAs act as biomarkers for diagnosis and prognosis of non-small cell lung cancer. Oncol Lett. 2021;22:792.","journal-title":"Oncol Lett"},{"key":"1505_CR38","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.7150\/ijbs.33986","volume":"15","author":"X Yang","year":"2019","unstructured":"Yang X, Zhang Q, Zhang M, Su W, Wang Z, Li Y, et al. Serum microRNA signature is capable of early diagnosis for non-small cell lung cancer. Int J Biol Sci. 2019;15:1712\u201322.","journal-title":"Int J Biol Sci"},{"key":"1505_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23505","volume":"34","author":"C Zhou","year":"2020","unstructured":"Zhou C, Chen Z, Zhao L, Zhao W, Zhu Y, Liu J, et al. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non\u2013small-cell lung cancer. J Clin Lab Anal. 2020;34:e23505.","journal-title":"J Clin Lab Anal"},{"key":"1505_CR40","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.21037\/tlcr-20-959","volume":"10","author":"L MacDonagh","year":"2021","unstructured":"MacDonagh L, Gallagher MF, Ffrench B, Gasch C, Gray SG, Reidy M, et al. MicroRNA expression profiling and biomarker validation in treatment-na\u00efve and drug resistant non-small cell lung cancer. Transl Lung Cancer Res. 2021;10:1773\u201391.","journal-title":"Transl Lung Cancer Res"},{"key":"1505_CR41","doi-asserted-by":"publisher","first-page":"942","DOI":"10.3390\/cancers17060942","volume":"17","author":"KC Poh","year":"2025","unstructured":"Poh KC, Ren TM, Ling GL, Goh JSY, Rose S, Wong A, et al. Development of a miRNA-based model for lung cancer detection. Cancers. 2025;17:942.","journal-title":"Cancers"},{"key":"1505_CR42","doi-asserted-by":"publisher","unstructured":"Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non\u2013small cell lung cancer patients. Curr Probl Cancer. 2020;44. https:\/\/doi.org\/10.1016\/j.currproblcancer.2020.100540.","DOI":"10.1016\/j.currproblcancer.2020.100540"},{"key":"1505_CR43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/1759-7714.13800","volume":"12","author":"X Dong","year":"2021","unstructured":"Dong X, Chang M, Song X, Ding S, Xie L, Song X. Plasma miR-1247-5p, miR- 301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer. Thorac Cancer. 2021;12:539\u201348.","journal-title":"Thorac Cancer"},{"key":"1505_CR44","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.prp.2017.09.011","volume":"213","author":"T Powr\u00f3zek","year":"2017","unstructured":"Powr\u00f3zek T, Ku\u017anar-Kami\u0144ska B, Dziedzic M, Mlak R, Batura-Gabryel H, Sagan D, et al. The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection. Pathol Res Pract. 2017;213:1384\u20137.","journal-title":"Pathol Res Pract"},{"key":"1505_CR45","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13402-017-0334-8","volume":"40","author":"M Sromek","year":"2017","unstructured":"Sromek M, Glogowski M, Chechlinska M, Kulinczak M, Szafron L, Zakrzewska K, et al. Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection. Cell Oncol. 2017;40:529\u201336.","journal-title":"Cell Oncol"},{"key":"1505_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-025-03508-5","volume":"20","author":"W Liu","year":"2025","unstructured":"Liu W, Lu X, Yang C, Ji F, Wu X. microRNA-196b-5p expression in cancer tissues is closely associated with clinical and pathological characteristics and prognosis of patients with non-small cell lung cancer. J Cardiothorac Surg. 2025;20:264.","journal-title":"J Cardiothorac Surg"},{"key":"1505_CR47","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ccr.2006.01.025","volume":"9","author":"N Yanaihara","year":"2006","unstructured":"Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell. 2006;9:189\u201398.","journal-title":"Cancer Cell"},{"key":"1505_CR48","doi-asserted-by":"publisher","first-page":"6802","DOI":"10.1158\/1078-0432.CCR-11-0419","volume":"17","author":"X Tan","year":"2011","unstructured":"Tan X, Qin W, Zhang L, Hang J, Li B, Zhang C, et al. A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis. Clin Cancer Res. 2011;17:6802\u201311.","journal-title":"Clin Cancer Res"},{"key":"1505_CR49","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1158\/0008-5472.CAN-09-0587","volume":"69","author":"M Raponi","year":"2009","unstructured":"Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, et al. MicroRNA Classifiers for Predicting Prognosis of Squamous Cell Lung Cancer. Cancer Res. 2009;69:5776\u201383.","journal-title":"Cancer Res"},{"key":"1505_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13019-024-03220-w","volume":"20","author":"W Yang","year":"2025","unstructured":"Yang W, Liu L, Li J, Liu Y, Rong L, Ma J, et al. Abnormal expression of miR-668-3p in non-small cell lung cancer patients and its correlation with serum-related tumor markers. J Cardiothorac Surg. 2025;20:58.","journal-title":"J Cardiothorac Surg"},{"key":"1505_CR51","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/1759-7714.14331","volume":"13","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Zhang J, Yang J, Wei Y, Peng J, Fu C, et al. MiR-205-5p promotes lung cancer progression and is valuable for the diagnosis of lung cancer. Thorac Cancer. 2022;13:832\u201343.","journal-title":"Thorac Cancer"},{"key":"1505_CR52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3390\/cancers14010257","volume":"14","author":"KS Visan","year":"2022","unstructured":"Visan KS, Lobb RJ, Wen SW, Bedo J, Lima LG, Krumeich S, et al. Blood-Derived Extracellular Vesicle-Associated miR-3182 Detects Non-Small Cell Lung Cancer Patients. Cancers (Basel). 2022;14:257.","journal-title":"Cancers (Basel)"},{"key":"1505_CR53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/2211536611201010034","volume":"1","author":"JL Su","year":"2012","unstructured":"Su JL, Chen PS, Johansson G, Kuo ML. Function and regulation of let-7 family microRNAs. Microrna. 2012;1:34\u20139.","journal-title":"Microrna"},{"key":"1505_CR54","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1515\/cclm-2019-1329","volume":"58","author":"N Wang","year":"2020","unstructured":"Wang N, Guo W, Song X, Liu L, Niu L, Song X, et al. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer. Clin Chem Lab Med. 2020;58:1535\u201345.","journal-title":"Clin Chem Lab Med"},{"key":"1505_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8309015","volume":"2018","author":"SR Lamichhane","year":"2018","unstructured":"Lamichhane SR, Thachil T, De Ieso P, Gee H, Moss SA, Milic N. Prognostic Role of MicroRNAs in Human Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Dis Markers. 2018;2018:8309015.","journal-title":"Dis Markers"},{"key":"1505_CR56","doi-asserted-by":"publisher","first-page":"5311","DOI":"10.1158\/1078-0432.CCR-17-0577","volume":"23","author":"X Jin","year":"2017","unstructured":"Jin X, Chen Y, Chen H, Fei S, Chen D, Cai X, et al. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Clin Cancer Res. 2017;23:5311\u20139.","journal-title":"Clin Cancer Res"},{"key":"1505_CR57","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.3390\/cells10061520","volume":"10","author":"A Leonetti","year":"2021","unstructured":"Leonetti A, Capula M, Minari R, Mazzaschi G, Gregori A, El Hassouni B, et al. Dynamic Evaluation of Circulating miRNA Profile in EGFR-Mutated NSCLC Patients Treated with EGFR-TKIs. Cells. 2021;10:1520.","journal-title":"Cells"},{"key":"1505_CR58","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3390\/diagnostics11020274","volume":"11","author":"JA Wani","year":"2021","unstructured":"Wani JA, Majid S, Khan A, Arafah A, Ahmad A, Jan BL, et al. Clinico-Pathological Importance of miR-146a in Lung Cancer. Diagnostics. 2021;11:274.","journal-title":"Diagnostics"},{"key":"1505_CR59","unstructured":"Canatan D, S\u00f6nmez D, Y\u0131lmaz Y, Co\u015fkun H\u015e \u00d6, G\u00f6ksu SS, U\u00e7ar S, et al. MicroRNAs as a biomarker in lung cancer. Acta Biomed. 2023;94:e2023045."},{"key":"1505_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","volume":"13","author":"SL Yu","year":"2008","unstructured":"Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell. 2008;13:48\u201357.","journal-title":"Cancer Cell"},{"key":"1505_CR61","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-10-2961","volume":"17","author":"M Saito","year":"2011","unstructured":"Saito M, Schetter AJ, Mollerup S, Kohno T, Skaug V, Bowman ED, et al. The association of microRNA expression with prognosis and progression in early stage, non small cell lung adenocarcinoma: a retrospective analysis of three cohorts. Clin Cancer Res. 2011;17:1875\u201382.","journal-title":"Clin Cancer Res"},{"key":"1505_CR62","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1373\/clinchem.2007.101741","volume":"54","author":"A Markou","year":"2008","unstructured":"Markou A, Tsaroucha EG, Kaklamanis L, Fotinou M, Georgoulias V, Lianidou ES. Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin Chem. 2008;54:1696\u2013704.","journal-title":"Clin Chem"},{"key":"1505_CR63","first-page":"7726","volume":"7","author":"Z Zhao","year":"2014","unstructured":"Zhao Z, Liu J, Wang C, Wang Y, Jiang Y, Guo M. MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2. Int J Clin Exp Pathol. 2014;7:7726\u201334.","journal-title":"Int J Clin Exp Pathol"},{"key":"1505_CR64","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1002\/cncr.25907","volume":"117","author":"T Donnem","year":"2011","unstructured":"Donnem T, Lonvik K, Eklo K, Berg T, Sorbye SW, Al-Shibli K, et al. Independent and tissue-specific prognostic impact of miR-126 in nonsmall cell lung cancer: coexpression with vascular endothelial growth factor-A predicts poor survival. Cancer. 2011;117:3193\u2013200.","journal-title":"Cancer"},{"key":"1505_CR65","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1515\/med-2021-0312","volume":"16","author":"B Sun","year":"2021","unstructured":"Sun B, Cong D, Chen K, Bai Y, Li J. Prognostic value of microRNA-4521 in non-small cell lung cancer and its regulatory effect on tumor progression. Open Med. 2021;16:1150\u20139.","journal-title":"Open Med"},{"key":"1505_CR66","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","volume":"64","author":"J Takamizawa","year":"2004","unstructured":"Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 2004;64:3753\u20136.","journal-title":"Cancer Res"},{"key":"1505_CR67","first-page":"98","volume":"10","author":"SM Hosseini","year":"2018","unstructured":"Hosseini SM, Soltani BM, Tavallaei M, Mowla SJ, Tafsiri E, Bagheri A, et al. Clinically significant dysregulation of hsa-miR-30d-5p and hsa-let-7b expression in patients with surgically resected non-small cell lung cancer. Avicenna J Med Biotechnol. 2018;10:98\u2013104.","journal-title":"Avicenna J Med Biotechnol"},{"key":"1505_CR68","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s12253-018-0552-z","volume":"25","author":"J Zheng","year":"2019","unstructured":"Zheng J, Xu T, Chen F, Zhang Y. MiRNA-195-5p functions as a tumor suppressor and a predictive of poor prognosis in non-small cell lung cancer by directly targeting CIAPIN1. Pathol Oncol Res. 2019;25:1181\u201390.","journal-title":"Pathol Oncol Res"},{"key":"1505_CR69","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1159\/000488823","volume":"46","author":"RQ He","year":"2018","unstructured":"He RQ, Cen WL, Cen JM, Cen WN, Li JY, Li MW, et al. Clinical significance of miR-210 and its prospective signaling pathways in non-small cell lung cancer: evidence from Gene Expression Omnibus and the Cancer Genome Atlas data mining with 2763 samples and validation via real-time quantitative PCR. Cell Physiol Biochem. 2018;46:925\u201352.","journal-title":"Cell Physiol Biochem"},{"key":"1505_CR70","doi-asserted-by":"publisher","first-page":"e60317","DOI":"10.1371\/journal.pone.0060317","volume":"8","author":"G Chen","year":"2013","unstructured":"Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, et al. miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One. 2013;8:e60317.","journal-title":"PLoS One"},{"key":"1505_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-85793-7","volume":"15","author":"H Zheng","year":"2025","unstructured":"Zheng H, Fan S, Luo J, Wen Q, Zang H. MicroRNA-150-3p enhances the antitumour effects of CGP57380 and is associated with a favourable prognosis in non-small cell lung cancer. Sci Rep. 2025;15:1973.","journal-title":"Sci Rep"},{"key":"1505_CR72","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.3892\/or.2017.5612","volume":"37","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Sui J, Shen X, Li C, Yao W, Hong W, et al. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Oncol Rep. 2017;37:3543\u201353.","journal-title":"Oncol Rep"},{"key":"1505_CR73","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3892\/or.2013.2611","volume":"30","author":"Y Chen","year":"2013","unstructured":"Chen Y, Min L, Zhang X, Hu S, Wang B, Liu W, et al. Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. Oncol Rep. 2013;30:1832\u201340.","journal-title":"Oncol Rep"},{"key":"1505_CR74","doi-asserted-by":"publisher","first-page":"16753","DOI":"10.1007\/s00432-023-05404-8","volume":"149","author":"R Wu","year":"2023","unstructured":"Wu R, Zhang B, He M, Kang Y, Zhang G. MicroRNA biomarkers and their use in evaluating the prognosis of lung cancer. J Cancer Res Clin Oncol. 2023;149:16753\u201361.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1505_CR75","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.pulmoe.2021.05.005","volume":"29","author":"T Jia","year":"2023","unstructured":"Jia T, Zhang Q, Xu H, Liu H, Gu X. The function of miR-637 in non-small cell lung cancer progression and prognosis. Pulmonology. 2023;29:111\u20138.","journal-title":"Pulmonology"},{"key":"1505_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-026-02821-4","volume":"26","author":"S Nistala","year":"2026","unstructured":"Nistala S, Niyonzima J, Chahal R, Hasan A, Ho E, Janssens A, et al. Artificial intelligence and machine learning in non-small cell lung cancer: the current state of the science on multi-omic applications. BMC Med Res Methodol. 2026;26:86.","journal-title":"BMC Med Res Methodol"},{"key":"1505_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1260374","volume":"13","author":"M \u00c7al\u0131\u015fkan","year":"2023","unstructured":"\u00c7al\u0131\u015fkan M, Tazaki K. AI\/ML advances in non-small cell lung cancer biomarker discovery. Front Oncol. 2023;13:1260374.","journal-title":"Front Oncol"},{"key":"1505_CR78","doi-asserted-by":"publisher","unstructured":"Zehra T, Koopaie M, Fatima N, Rashid G, Hasan I, Siddiqui Z. Artificial intelligence-based miRNA analysis for precision oncology: diagnostic and prognostic insights. Front Mol Biosci. 2026:5;13. https:\/\/doi.org\/10.3389\/fmolb.2026.1749586.","DOI":"10.3389\/fmolb.2026.1749586"},{"key":"1505_CR79","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/bios15090610","volume":"15","author":"Y Chen","year":"2025","unstructured":"Chen Y, Chen D, Liu X, Jiang H, Wang X. Deep learning-driven multimodal integration of miRNA and radiomic for lung cancer diagnosis. Biosens. 2025;15:610.","journal-title":"Biosens"},{"key":"1505_CR80","volume":"16","author":"T Sinha","year":"2024","unstructured":"Sinha T, Khan A, Awan M, Bokhari SFH, Ali K, Amir M, et al. Artificial intelligence and machine learning in predicting the response to immunotherapy in non-small cell lung carcinoma: a systematic review. Cureus. 2024;16:e61220.","journal-title":"Cureus"},{"key":"1505_CR81","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/2211536611666220818145553","volume":"11","author":"CD Christou","year":"2022","unstructured":"Christou CD, Mitsas AC, Vlachavas I, Tsoulfas G. The use of machine learning in MicroRNA diagnostics: current perspectives. Microrna. 2022;11:175\u201384.","journal-title":"Microrna"},{"key":"1505_CR82","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/diagnostics15212735","volume":"15","author":"YJ Kim","year":"2025","unstructured":"Kim YJ, Kang DH, Cho H, Chung C, Lee JE, Shin YB. Exosomal microRNA panels for detecting early-stage non-small cell lung cancer. Diagnostics. 2025;15:21.","journal-title":"Diagnostics"},{"key":"1505_CR83","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1111\/1759-7714.13644","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Jiang X, Li J, Wang J, Binang H, Shi S, et al. Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer. Thorac Cancer. 2020;11:3436\u201347.","journal-title":"Thorac Cancer"},{"key":"1505_CR84","first-page":"712","volume":"48","author":"M Feng","year":"2018","unstructured":"Feng M, Zhao J, Wang L, Liu J. Upregulated expression of serum exosomal microRNAs as diagnostic biomarkers of lung adenocarcinoma. Ann Clin Lab Sci. 2018;48:712\u20138.","journal-title":"Ann Clin Lab Sci"},{"key":"1505_CR85","doi-asserted-by":"publisher","first-page":"6513","DOI":"10.18632\/oncotarget.14311","volume":"8","author":"X Zhou","year":"2016","unstructured":"Zhou X, Wen W, Shan X, Zhu W, Xu J, Guo R, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. Oncotarget. 2016;8:6513\u201325.","journal-title":"Oncotarget"},{"key":"1505_CR86","doi-asserted-by":"publisher","first-page":"3382","DOI":"10.1002\/jcb.29612","volume":"121","author":"L Chen","year":"2020","unstructured":"Chen L, Cao P, Huang C, Wu Q, Chen S, Chen F. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma. J Cell Biochem. 2020;121:3382\u201391.","journal-title":"J Cell Biochem"},{"key":"1505_CR87","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/jcmm.13056","volume":"21","author":"H Wu","year":"2017","unstructured":"Wu H, Zhou J, Mei S, Wu D, Mu Z, Chen B, et al. Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med. 2017;21:1228\u201336.","journal-title":"J Cell Mol Med"},{"key":"1505_CR88","doi-asserted-by":"publisher","first-page":"13048","DOI":"10.18632\/oncotarget.14369","volume":"8","author":"Q Liu","year":"2017","unstructured":"Liu Q, Yu Z, Yuan S. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Oncotarget. 2017;8:13048\u201358.","journal-title":"Oncotarget"},{"key":"1505_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03308-w","volume":"12","author":"DH Kim","year":"2021","unstructured":"Kim DH, Park H, Choi YJ, Kang MH, Kim TK, Pack CG. Exosomal miR- 1260b derived from non-small cell lung cancer promotes tumor metastasis through the inhibition of HIPK2. Cell Death Dis. 2021;12:8.","journal-title":"Cell Death Dis"},{"key":"1505_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15475-6","volume":"7","author":"F Grimolizzi","year":"2017","unstructured":"Grimolizzi F, Monaco F, Leoni F, Bracci M, Staffolani S, Bersaglieri C, et al. Exosomal miR-126 as a circulating biomarker in non-small-cell lung cancer regulating cancer progression. Sci Rep. 2017;7:15277.","journal-title":"Sci Rep"},{"key":"1505_CR91","doi-asserted-by":"publisher","first-page":"86897","DOI":"10.18632\/oncotarget.19666","volume":"8","author":"L Zhang","year":"2017","unstructured":"Zhang L, Shan X, Wang J, Zhu J, Huang Z, Zhang H, et al. A three-microRNA signature for lung squamous cell carcinoma diagnosis in Chinese male patients. Oncotarget. 2017;8:86897\u2013907.","journal-title":"Oncotarget"},{"key":"1505_CR92","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/JTO.0b013e318299ac32","volume":"8","author":"R Cazzoli","year":"2013","unstructured":"Cazzoli R, Buttitta F, Di Nicola M, Malatesta S, Marchetti A, Rom WN, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013;8:1156\u201362.","journal-title":"J Thorac Oncol"},{"key":"1505_CR93","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1080\/0284186X.2018.1465585","volume":"57","author":"AR Halvorsen","year":"2018","unstructured":"Halvorsen AR, Sandhu V, Sprauten M, Flote VG, Kure EH, Brustugun OT, et al. Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab. Acta Oncol. 2018;57:1225\u201331.","journal-title":"Acta Oncol"},{"key":"1505_CR94","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/annonc\/mdn006","volume":"19","author":"GJ Weiss","year":"2008","unstructured":"Weiss GJ, Bemis LT, Nakajima E, Sugita M, Birks DK, Robinson WA, et al. EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines. Ann Oncol. 2008;19:1053\u20139.","journal-title":"Ann Oncol"},{"key":"1505_CR95","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.3332\/ecancer.2025.1989","volume":"19","author":"C Wang","year":"2025","unstructured":"Wang C, Jiang S, Bi J, Xu X. Predictive value of circulating microRNA-21 levels in patients with advanced non-small cell lung cancer treated with immunotherapy. Ecancermedicalscience. 2025;19:1989.","journal-title":"Ecancermedicalscience"},{"key":"1505_CR96","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0750-1","volume":"30","author":"Y Shen","year":"2013","unstructured":"Shen Y, Tang D, Yao R, Wang M, Wang Y, Yao Y, et al. microRNA expression profiles associated with survival, disease progression, and response to gefitinib in completely resected non-small-cell lung cancer with EGFR mutation. Med Oncol. 2013;30:750.","journal-title":"Med Oncol"},{"key":"1505_CR97","first-page":"24","volume":"16","author":"MAM Mansoor","year":"2024","unstructured":"Mansoor MAM, Zhu X, Ashiqueali SA, Alam MT, Winiarska H, Pazdrowski P, et al. Circulating microRNAs as a prognostic tool to determine treatment efficacy in lung cancer patients undergoing pembrolizumab PD-1 blockade immunotherapy. Cancers. 2024;16:24.","journal-title":"Cancers"},{"key":"1505_CR98","first-page":"1","volume":"17","author":"Y Wu","year":"2014","unstructured":"Wu Y, Guo L, Liu J, Liu R, Liu M, Chen J. The reversing and molecular mechanisms of miR-503 on the drug-resistance to cisplatin in A549\/DDP cells. Zhongguo Fei Ai Za Zhi. 2014;17:1\u20137.","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"1505_CR99","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1007\/s13277-015-4017-7","volume":"37","author":"JH Li","year":"2016","unstructured":"Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX, Yao XY, et al. Inhibition of microRNA-196a might reverse cisplatin resistance of A549\/DDP non-small-cell lung cancer cell line. Tumour Biol. 2016;37:2387\u201394.","journal-title":"Tumour Biol"},{"key":"1505_CR100","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/mt.2011.48","volume":"19","author":"P Trang","year":"2011","unstructured":"Trang P, Wiggins JF, Daige CL, Cho C, Omotola M, Brown D, et al. Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice. Mol Ther. 2011;19:1116\u201322.","journal-title":"Mol Ther"},{"key":"1505_CR101","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1007\/s13277-014-1663-0","volume":"35","author":"Y Xia","year":"2014","unstructured":"Xia Y, Zhu Y, Zhou X, Chen Y. Low expression of let-7 predicts poor prognosis in patients with multiple cancers: a meta-analysis. Tumour Biol. 2014;35:5143\u20138.","journal-title":"Tumour Biol"},{"key":"1505_CR102","doi-asserted-by":"publisher","first-page":"759","DOI":"10.4161\/cc.7.6.5834","volume":"7","author":"A Esquela-Kerscher","year":"2008","unstructured":"Esquela-Kerscher A, Trang P, Wiggins JF, Patrawala L, Cheng A, Ford L, et al. The let-7 microRNA reduces tumor growth in mouse models of lung cancer. Cell Cycle. 2008;7:759\u201364.","journal-title":"Cell Cycle"},{"key":"1505_CR103","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1080\/15384101.2014.1003008","volume":"14","author":"C Stahlhut","year":"2015","unstructured":"Stahlhut C, Slack FJ. Combinatorial action of microRNAs let-7 and miR-34 effectively synergizes with erlotinib to suppress non-small cell lung cancer cell proliferation. Cell Cycle. 2015;14:2171\u201380.","journal-title":"Cell Cycle"},{"key":"1505_CR104","doi-asserted-by":"crossref","unstructured":"Li YL, Liu XM, Zhang CY, Zhou JB, Shao Y, Liang C, et al. MicroRNA-34a\/EGFR axis plays pivotal roles in lung tumorigenesis. Oncogenesis. 2017;6:e372.","DOI":"10.1038\/oncsis.2017.50"},{"key":"1505_CR105","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/jmcb\/mjq040","volume":"3","author":"Z Feng","year":"2011","unstructured":"Feng Z, Zhang C, Wu R, Hu W. Tumor suppressor p53 meets microRNAs. J Mol Cell Biol. 2011;3:44\u201350.","journal-title":"J Mol Cell Biol"},{"key":"1505_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-703","volume":"14","author":"K Zhong","year":"2014","unstructured":"Zhong K, Chen K, Han L, Li B. MicroRNA-30b\/c inhibits non-small cell lung cancer cell proliferation by targeting Rab18. BMC Cancer. 2014;14:703.","journal-title":"BMC Cancer"},{"key":"1505_CR107","doi-asserted-by":"publisher","first-page":"5638","DOI":"10.1002\/cam4.2489","volume":"8","author":"X Jia","year":"2019","unstructured":"Jia X, Wang X, Guo X, Ji J, Lou G, Zhao J, et al. MicroRNA-124: an emerging therapeutic target in cancer. Cancer Med. 2019;8:5638\u201350.","journal-title":"Cancer Med"},{"key":"1505_CR108","doi-asserted-by":"publisher","first-page":"3800","DOI":"10.1111\/j.1742-4658.2012.08741.x","volume":"279","author":"L Liu","year":"2012","unstructured":"Liu L, Shao X, Gao W, Zhang Z, Liu P, Wang R, et al. MicroRNA-133b inhibits the growth of non-small-cell lung cancer by targeting the epidermal growth factor receptor. FEBS J. 2012;279:3800\u201312.","journal-title":"FEBS J"},{"key":"1505_CR109","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.cca.2010.02.074","volume":"411","author":"Jguang Zhang","year":"2010","unstructured":"Zhang Jguang, Wang Jjun, Zhao F, Liu Q, Jiang K, Yang Ghai. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta. 2010;411:846\u201352.","journal-title":"Clin Chim Acta"},{"key":"1505_CR110","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1074\/jbc.M707224200","volume":"283","author":"LB Frankel","year":"2008","unstructured":"Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem. 2008;283:1026\u201333.","journal-title":"J Biol Chem"},{"key":"1505_CR111","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","volume":"18","author":"ME Hatley","year":"2010","unstructured":"Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18:282\u201393.","journal-title":"Cancer Cell"},{"key":"1505_CR112","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1038\/onc.2008.72","volume":"27","author":"Z Lu","year":"2008","unstructured":"Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008;27:4373\u20139.","journal-title":"Oncogene"},{"key":"1505_CR113","doi-asserted-by":"publisher","first-page":"14328","DOI":"10.1074\/jbc.M611393200","volume":"282","author":"S Zhu","year":"2007","unstructured":"Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem. 2007;282:14328\u201336.","journal-title":"J Biol Chem"},{"key":"1505_CR114","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/onc.2010.416","volume":"30","author":"D Frezzetti","year":"2011","unstructured":"Frezzetti D, De Menna M, Zoppoli P, Guerra C, Ferraro A, Bello AM, et al. Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene. 2011;30:275\u201386.","journal-title":"Oncogene"},{"key":"1505_CR115","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","volume":"103","author":"S Volinia","year":"2006","unstructured":"Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 2006;103:2257\u201361.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1505_CR116","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.7150\/jca.29426","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Wang D, Li X, Shao Y, He Y, Yu H, et al. MiR-199a-5p suppresses non-small cell lung cancer via targeting MAP3K11. J Cancer. 2019;10:2472\u20139.","journal-title":"J Cancer"},{"key":"1505_CR117","first-page":"12845","volume":"8","author":"XM Kong","year":"2015","unstructured":"Kong XM, Zhang GH, Huo YK, Zhao XH, Cao DW, Guo SF, et al. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2. Int J Clin Exp Pathol. 2015;8:12845\u201352.","journal-title":"Int J Clin Exp Pathol"},{"key":"1505_CR118","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000489803","volume":"47","author":"F Yang","year":"2018","unstructured":"Yang F, Wei K, Qin Z, Liu W, Shao C, Wang C, et al. MiR-598 suppresses invasion and migration by negative regulation of derlin-1 and epithelial-mesenchymal transition in non-small cell lung cancer. Cell Physiol Biochem. 2018;47:245\u201356.","journal-title":"Cell Physiol Biochem"},{"key":"1505_CR119","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2025.102019","volume":"80","author":"G Hu","year":"2025","unstructured":"Hu G, Cai P, Li J, Yu L, Zhao B, Chen G. Serum exosomal miR-454-3p contributes to malignant progression of lung cancer by inhibiting HHEX. Mol Cell Probes. 2025;80:102019.","journal-title":"Mol Cell Probes"},{"key":"1505_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1642999","volume":"15","author":"C Yi","year":"2025","unstructured":"Yi C, Zhang H, Guo Q, Lu L, Gao C, Zhao Y, et al. MiR-4664-3p as a potential diagnostic, prognostic, and immunotherapeutic biomarker in NSCLC: modulation of tumor progression through CD8+ T cell regulation. Front Oncol. 2025;15:1642999.","journal-title":"Front Oncol"},{"key":"1505_CR121","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","volume":"18","author":"N van Zandwijk","year":"2017","unstructured":"van Zandwijk N, Pavlakis N, Kao SC, Linton A, Boyer MJ, Clarke S, et al. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol. 2017;18:1386\u201396.","journal-title":"Lancet Oncol"},{"key":"1505_CR122","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.3390\/ijms231911502","volume":"23","author":"A Menon","year":"2022","unstructured":"Menon A, Abd-Aziz N, Khalid K, Poh CL, Naidu R. miRNA: a promising therapeutic target in cancer. Int J Mol Sci. 2022;23:11502.","journal-title":"Int J Mol Sci"},{"key":"1505_CR123","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10637-016-0407-y","volume":"35","author":"MS Beg","year":"2017","unstructured":"Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, et al. Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest N Drugs. 2017;35:180\u20138.","journal-title":"Invest N Drugs"},{"key":"1505_CR124","doi-asserted-by":"publisher","first-page":"TPS2666","DOI":"10.1200\/JCO.2021.39.15_suppl.TPS2666","volume":"39","author":"N Kotecki","year":"2021","unstructured":"Kotecki N, Opdam F, Robbrecht D, Strijbos M, Kroon K, Janicot M, et al. Phase I\/Ib study with INT-1B3, a novel LNP-formulated micro-RNA (miR-193a-3p mimic) therapeutic for patients with advanced solid cancer. J Clin Oncol. 2021;39:TPS2666\u2013TPS2666.","journal-title":"J Clin Oncol"},{"key":"1505_CR125","doi-asserted-by":"publisher","first-page":"422","DOI":"10.18632\/oncotarget.27894","volume":"12","author":"BJ Telford","year":"2021","unstructured":"Telford BJ, Yahyanejad S, de Gunst T, den Boer HC, Vos RM, Stegink M, et al. Multi-modal effects of 1B3, a novel synthetic miR-193a-3p mimic, support strong potential for therapeutic intervention in oncology. Oncotarget. 2021;12:422\u201339.","journal-title":"Oncotarget"},{"key":"1505_CR126","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.omtn.2021.01.020","volume":"23","author":"MTJ van den Bosch","year":"2021","unstructured":"van den Bosch MTJ, Yahyanejad S, Alemdehy MF, Telford BJ, de Gunst T, den Boer HC, et al. Transcriptome-wide analysis reveals insight into tumor suppressor functions of 1B3, a novel synthetic miR-193a-3p mimic. Mol Ther Nucleic Acids. 2021;23:1161\u201371.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1505_CR127","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40291-017-0285-9","volume":"21","author":"N Petrovic","year":"2017","unstructured":"Petrovic N, Erg\u00fcn S, Isenovic ER. Levels of MicroRNA heterogeneity in cancer biology. Mol Diagn Ther. 2017;21:511\u201323.","journal-title":"Mol Diagn Ther"},{"key":"1505_CR128","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/ijms22031176","volume":"22","author":"F Precazzini","year":"2021","unstructured":"Precazzini F, Detassis S, Imperatori AS, Denti MA, Campomenosi P. Measurements methods for the development of microRNA-based tests for cancer diagnosis. Int J Mol Sci. 2021;22:1176.","journal-title":"Int J Mol Sci"},{"key":"1505_CR129","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1080\/10408444.2021.1907530","volume":"51","author":"BN Chorley","year":"2021","unstructured":"Chorley BN, Atabakhsh E, Doran G, Gautier JC, Ellinger-Ziegelbauer H, Jackson D, et al. Methodological considerations for measuring biofluid-based microRNA biomarkers. Crit Rev Toxicol. 2021;51:264\u201382.","journal-title":"Crit Rev Toxicol"},{"key":"1505_CR130","doi-asserted-by":"publisher","unstructured":"Huang M, Ge Y, Chen H, Wei C, Cogdell D, Ivan C, et al. Stage- and smoking-associated microRNA expression in lung adenocarcinoma. Transl Lung Cancer Res. 2025;14. https:\/\/doi.org\/10.21037\/tlcr-2025-636.","DOI":"10.21037\/tlcr-2025-636"},{"key":"1505_CR131","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-14-778","volume":"14","author":"EA Vucic","year":"2014","unstructured":"Vucic EA, Thu KL, Pikor LA, Enfield KS, Yee J, English JC, et al. Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology. BMC Cancer. 2014;14:778.","journal-title":"BMC Cancer"},{"key":"1505_CR132","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1158\/2767-9764.CRC-24-0262","volume":"4","author":"L Gao","year":"2024","unstructured":"Gao L, Dhilipkannah P, Jiang F. Identification of ncRNA biomarkers in non\u2013small cell lung cancer to address racial disparities. Cancer Res Commun. 2024;4:3201\u20138.","journal-title":"Cancer Res Commun"},{"key":"1505_CR133","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.1158\/1078-0432.CCR-17-0527","volume":"23","author":"KA Mitchell","year":"2017","unstructured":"Mitchell KA, Zingone A, Toulabi L, Boeckelman J, Ryan BM. Comparative transcriptome profiling reveals coding and noncoding RNA differences in NSCLC from African Americans and European Americans. Clin Cancer Res. 2017;23:7412\u201325.","journal-title":"Clin Cancer Res"},{"key":"1505_CR134","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1007\/s00018-019-03136-y","volume":"76","author":"S Madadi","year":"2019","unstructured":"Madadi S, Schwarzenbach H, Lorenzen J, Soleimani M. MicroRNA expression studies: challenge of selecting reliable reference controls for data normalization. Cell Mol Life Sci. 2019;76:3497\u2013514.","journal-title":"Cell Mol Life Sci"},{"key":"1505_CR135","doi-asserted-by":"crossref","unstructured":"Sui JYAX. MiRNA-30 play an important role in non-small cell lung cancer (NSCLC). Clin Lab. 2020;66:529\u201335.","DOI":"10.7754\/Clin.Lab.2019.190712"},{"key":"1505_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033820964222","volume":"19","author":"L Chen","year":"2020","unstructured":"Chen L, Li Y, Lu J. Identification of circulating miR-762 as a novel diagnostic and prognostic biomarker for non-small cell lung cancer. Technol Cancer Res Treat. 2020;19:1\u20139.","journal-title":"Technol Cancer Res Treat"},{"key":"1505_CR137","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells10081988","volume":"10","author":"A Monastirioti","year":"2021","unstructured":"Monastirioti A, Papadaki C, Rounis K, Kalapanida D, Mavroudis D, Agelaki S. A prognostic role for circulating microRNAs involved in macrophage polarization in advanced non-small cell lung cancer. Cells. 2021;10:8.","journal-title":"Cells"},{"key":"1505_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2020.597508","volume":"11","author":"M Liu","year":"2020","unstructured":"Liu M, Si Q, Ouyang S, Zhou Z, Wang M, Zhao C. Serum MiR-4687-3p has potential for diagnosis and carcinogenesis in non-small cell lung cancer. Front Genet. 2020;11:1\u201310.","journal-title":"Front Genet"},{"key":"1505_CR139","doi-asserted-by":"publisher","first-page":"74554","DOI":"10.18632\/oncotarget.20218","volume":"8","author":"Y Hu","year":"2017","unstructured":"Hu Y, Wang L, Gu J, Qu K, Wang Y. Identification of MicroRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis. Oncotarget. 2017;8:74554\u201366.","journal-title":"Oncotarget"},{"key":"1505_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-021-02376-2","volume":"19","author":"M Zuo","year":"2021","unstructured":"Zuo M, Yao L, Wen L, Shen J, Zhang N, Bai T. The expression of miRNA- 216b is negatively correlated with 18F-FDG uptake in non-small cell lung cancer. World J Surg Oncol. 2021;19:1\u201310.","journal-title":"World J Surg Oncol"},{"key":"1505_CR141","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.3892\/ol.2020.11667","volume":"20","author":"X Zhang","year":"2020","unstructured":"Zhang X, Hu Y, Gong C, Zhang C. Overexpression of miR-518b in non-small cell lung cancer serves as a biomarker and facilitates tumor cell proliferation, migration and invasion. Oncol Lett. 2020;20:1213\u201320.","journal-title":"Oncol Lett"},{"key":"1505_CR142","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7150\/jca.16644","volume":"8","author":"S Lv","year":"2017","unstructured":"Lv S, Xue J, Wu C. Identification of a panel of serum microRNAs as biomarkers for early detection of lung adenocarcinoma. J Cancer. 2017;8:48\u201356.","journal-title":"J Cancer"},{"key":"1505_CR143","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033820973276","volume":"19","author":"J Liu","year":"2020","unstructured":"Liu J, Han Y, Liu X, Wei S. Serum miR-185 is a diagnostic and prognostic biomarker for non-small cell lung cancer. Technol Cancer Res Treat. 2020;19:1\u20137.","journal-title":"Technol Cancer Res Treat"},{"key":"1505_CR144","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s13577-020-00351-9","volume":"33","author":"S Kumar","year":"2020","unstructured":"Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Pandey M. Differential expression of circulating serum miR-1249-3p, miR-3195, and miR-3692-3p in non-small cell lung cancer. Hum Cell. 2020;33:839\u201349.","journal-title":"Hum Cell"},{"key":"1505_CR145","doi-asserted-by":"crossref","unstructured":"Liao J, Shen J, Leng Q, Qin M, Zhan M, Jiang F MicroRNA-based biomarkers for diagnosis of non-small cell lung cancer (NSCLC). Thorac Cancer. 2020:11.","DOI":"10.1111\/1759-7714.13337"},{"key":"1505_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1533033820947490","volume":"19","author":"H Xie","year":"2020","unstructured":"Xie H, Chen J, Lv X, Zhang L, Wu J, Ge X. Clinical value of serum and exhaled breath condensate miR-186 and IL-1b levels in non-small cell lung cancer. Technol Cancer Res Treat. 2020;19:1\u20138.","journal-title":"Technol Cancer Res Treat"},{"key":"1505_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.673926","volume":"12","author":"X Duan","year":"2021","unstructured":"Duan X, Qiao S, Li D. Circulating MiRNAs in serum as biomarkers for early diagnosis of Non-small cell lung cancer. Front Genet. 2021;12:673926.","journal-title":"Front Genet"},{"key":"1505_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2020.12099","volume":"20","author":"J Lv","year":"2020","unstructured":"Lv J, An J, Zhang YD, Li ZX, Zhao GL, Gao J. A three serum miRNA panel as diagnostic biomarkers of radiotherapy-related metastasis in non-small cell lung cancer. Oncol Lett. 2020;20:1\u201311.","journal-title":"Oncol Lett"},{"key":"1505_CR149","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/cancers12051282","volume":"12","author":"C Papadaki","year":"2020","unstructured":"Papadaki C, Monastirioti A, Rounis K, Makrakis D, Kalbakis K, Nikolaou C. Circulating microRNAs regulating DNA damage response and responsiveness to cisplatin in the prognosis of patients with non-small cell lung cancer treated with first-line platinum chemotherapy. Cancers. 2020;12:5.","journal-title":"Cancers"},{"key":"1505_CR150","first-page":"5073","volume":"13","author":"L Shao","year":"2021","unstructured":"Shao L, Lu X, Zhou Y, Wang Y, Wang X, Zhuang Z. Altered miR-93-5p\/ miR-18a expression in serum for diagnosing non-small cell lung cancer. Am J Transl Res. 2021;13:5073\u20139.","journal-title":"Am J Transl Res"},{"key":"1505_CR151","doi-asserted-by":"publisher","unstructured":"Wan N, Zheng J MicroRNA-891a-5p is a novel biomarker for non-small cell lung cancer and targets HOXA5 to regulate tumor cell biological function. Oncol Lett. 2021;22. https:\/\/doi.org\/10.3892\/ol.2021.12768.","DOI":"10.3892\/ol.2021.12768"},{"key":"1505_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/srep12464","volume":"5","author":"E Nadal","year":"2015","unstructured":"Nadal E, Truini A, Nakata A. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep. 2015;5:12464.","journal-title":"Sci Rep"},{"key":"1505_CR153","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/cas.14199","volume":"111","author":"A Khandelwal","year":"2020","unstructured":"Khandelwal A, Seam RK, Gupta M, Rana MK, Prakash H, Vasquez KM. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci. 2020;111:826\u201339.","journal-title":"Cancer Sci"},{"key":"1505_CR154","volume":"2021","author":"F Liu","year":"2021","unstructured":"Liu F, Li T, Hu P, Dai L. Upregulation of serum miR-629 predicts poor prognosis for non-small-cell lung cancer. Dis Markers. 2021;2021:8819934.","journal-title":"Dis Markers"},{"key":"1505_CR155","doi-asserted-by":"publisher","unstructured":"Li N, Dhilipkannah P, Jiang F. High-throughput detection of multiple miRNAs and methylated DNA by droplet digital PCR. J Pers Med. 2021;11. https:\/\/doi.org\/10.3390\/jpm11050359.","DOI":"10.3390\/jpm11050359"},{"key":"1505_CR156","doi-asserted-by":"publisher","unstructured":"Wu J, Han X, Yang X, Li Y, Liang Y, Sun G. MiR-138-5p suppresses the progression of lung cancer by targeting SNIP1. Thorac Cancer. 2022;2023:1\u201312. https:\/\/doi.org\/10.1111\/1759-7714.14791.","DOI":"10.1111\/1759-7714.14791"},{"key":"1505_CR157","doi-asserted-by":"publisher","unstructured":"Zhou C, Chen Z, Zhao L. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer. J Clin Lab Anal. 2020;34. https:\/\/doi.org\/10.1002\/jcla.23505.","DOI":"10.1002\/jcla.23505"},{"key":"1505_CR158","doi-asserted-by":"publisher","unstructured":"Identification using microarray datasets and bioinformatics methods. J Pers Med. 2022;12. https:\/\/doi.org\/10.3390\/jpm12122056.","DOI":"10.3390\/jpm12122056"},{"key":"1505_CR159","doi-asserted-by":"publisher","first-page":"831997","DOI":"10.3389\/fonc.2022.831997","volume":"12","author":"X Jiang","year":"2022","unstructured":"Jiang X, Yuan Y, Tang L, Wang J, Zhang D, Cho WC. Identification and validation prognostic impact of MiRNA-30a-5p in lung adenocarcinoma. Front Oncol. 2022;12:831997.","journal-title":"Front Oncol"},{"key":"1505_CR160","doi-asserted-by":"publisher","unstructured":"Khandelwal A, Sharma U, Barwal TS, Seam RK, Gupta M, Rana M. Circulating miR-320a acts as a tumor suppressor and prognostic factor in non-small cell lung cancer. Front Oncol. 2021;11. https:\/\/doi.org\/10.3389\/fonc.2021.645475.","DOI":"10.3389\/fonc.2021.645475"},{"key":"1505_CR161","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-025-04091-4","volume":"26","author":"S Tahmasebi","year":"2025","unstructured":"Tahmasebi S, Amani D, Adcock IM, Mortaz E. Harnessing miR-145 in NSCLC: mechanistic roles, diagnostic-prognostic utility, and therapeutic potential. Cancer Cell Int. 2025;26:7.","journal-title":"Cancer Cell Int"},{"key":"1505_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342337","volume":"1296","author":"Z Tong","year":"2024","unstructured":"Tong Z, Yang D, Shen C, Li C, Xu X, Li Q. Rapid automated extracellular vesicle isolation and miRNA preparation on a cost-effective digital microfluidic platform. Anal Chim Acta. 2024;1296:342337.","journal-title":"Anal Chim Acta"},{"key":"1505_CR163","first-page":"1601","volume":"13","author":"D Huang","year":"2020","unstructured":"Huang D, Qu D. Early diagnostic and prognostic value of serum exosomal miR- 1246 in non-small cell lung cancer. Int J Clin Exp Pathol. 2020;13:1601\u20137.","journal-title":"Int J Clin Exp Pathol"},{"key":"1505_CR164","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.133594","volume":"275","author":"M Lv","year":"2024","unstructured":"Lv M, Li X, Zheng C, Tian W, Yang H, Yin Z, et al. Exosomal miR-130b-3p suppresses metastasis of non-small cell lung cancer cells by targeting DEPDC1 via TGF-\u03b2 signaling pathway. Int J Biol Macromol. 2024;275:133594.","journal-title":"Int J Biol Macromol"},{"key":"1505_CR165","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1138230","volume":"14","author":"L Feng","year":"2023","unstructured":"Feng L, Feng Z, Hu J, Gao J, Li A, He X. Identification of hsa-miR- 619-5p and hsa-miR-4454 in plasma-derived exosomes as a potential biomarker for lung adenocarcinoma. Front Genet. 2023;14:1138230.","journal-title":"Front Genet"},{"key":"1505_CR166","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/02648725.2023.2191069","volume":"40","author":"H Li","year":"2024","unstructured":"Li H, Xia M, Zheng S, Lin Y, Yu T, Xie Y, et al. Cerebrospinal fluid exosomal microRNAs as biomarkers for diagnosing or monitoring the progression of non-small cell lung cancer with leptomeningeal metastases. Biotechnol Genet Eng Rev. 2024;40:359\u201380.","journal-title":"Biotechnol Genet Eng Rev"},{"key":"1505_CR167","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/ajco.13343","volume":"16","author":"G Yang","year":"2020","unstructured":"Yang G, Wang T, Qu X, Chen S, Han Z, Chen S. Exosomal miR-21\/Let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases. Asia Pac J Clin Oncol. 2020;16:280\u20136.","journal-title":"Asia Pac J Clin Oncol"},{"key":"1505_CR168","doi-asserted-by":"publisher","unstructured":"Tang Y, Zhang Z, Song X, Yu M, Niu L, Zhao Y. Tumor-derived exosomal miR-620 as a diagnostic biomarker in non-small-cell lung cancer. J Oncol. 2020. https:\/\/doi.org\/10.1155\/2020\/6691211.","DOI":"10.1155\/2020\/6691211"},{"key":"1505_CR169","doi-asserted-by":"publisher","first-page":"21059","DOI":"10.1016\/j.heliyon.2023.e21059","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zheng K, Gao Y, Zhao S, Zhao Y, Li W. Plasma exosomal miR-1290 and miR-29c-3p as diagnostic biomarkers for lung cancer. Heliyon. 2023;9:21059.","journal-title":"Heliyon"},{"key":"1505_CR170","doi-asserted-by":"publisher","unstructured":"Zheng Q, Ding H, Wang L, Yan Y, Wan Y, Yi Y. Circulating exosomal miR- 96 as a novel biomarker for radioresistant non-small-cell lung cancer. J Oncol. 2021;2021. https:\/\/doi.org\/10.1155\/2021\/5893981.","DOI":"10.1155\/2021\/5893981"},{"key":"1505_CR171","doi-asserted-by":"publisher","first-page":"15835","DOI":"10.1007\/s13277-016-5410-6","volume":"37","author":"J Lin","year":"2016","unstructured":"Lin J, Wang Y, Zou YQ. Differential miRNA expression in pleural effusions derived from extracellular vesicles of patients with lung cancer, pulmonary tuberculosis, or pneumonia. Tumour Biol. 2016;37:15835\u201345.","journal-title":"Tumour Biol"},{"key":"1505_CR172","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.21037\/jtd-23-398","volume":"15","author":"M Li","year":"2023","unstructured":"Li M, Liu T, Cheng W, Jin H, Wang X. A test of miR-128-3p and miR-33a-5p in serum exosome as biomarkers for auxiliary diagnosis of non-small cell lung cancer. J Thorac Dis. 2023;15:2616\u201326.","journal-title":"J Thorac Dis"},{"key":"1505_CR173","doi-asserted-by":"publisher","first-page":"19793","DOI":"10.18632\/oncotarget.24857","volume":"9","author":"V Poroyko","year":"2018","unstructured":"Poroyko V, Mirzapoiazova T, Nam A. Exosomal miRNAs species in the blood of small cell and nonsmall cell lung cancer patients. Oncotarget. 2018;9:19793\u2013806.","journal-title":"Oncotarget"},{"key":"1505_CR174","doi-asserted-by":"publisher","first-page":"e8361","DOI":"10.1097\/MD.0000000000008361","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang Y, Xu YM, Zou YQ. Identification of differential expressed PE exosomal miRNA in lung adenocarcinoma, tuberculosis, and other benign lesions. Med Baltim. 2017;96:e8361.","journal-title":"Med Baltim"},{"key":"1505_CR175","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2018.07.018","volume":"124","author":"P Hydbring","year":"2018","unstructured":"Hydbring P, Petris L, Zhang Y. Exosomal RNA- profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression. Lung Cancer. 2018;124:45\u201352.","journal-title":"Lung Cancer"},{"key":"1505_CR176","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23237","volume":"34","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Xu H. Serum exosomal miR-378 upregulation is associated with poor prognosis in non\u2013small-cell lung cancer patients. J Clin Lab Anal. 2020;34:e23237.","journal-title":"J Clin Lab Anal"},{"key":"1505_CR177","doi-asserted-by":"publisher","first-page":"6707","DOI":"10.21873\/anticanres.13039","volume":"38","author":"H Tamiya","year":"2018","unstructured":"Tamiya H, Mitani A, Saito A. Exosomal microRNA expression profiling in patients with lung adenocarcinoma- associated malignant pleural effusion. Anticancer Res. 2018;38:6707\u201314.","journal-title":"Anticancer Res"},{"key":"1505_CR178","doi-asserted-by":"publisher","unstructured":"Zhang Z, Tang Y, Song X, Xie L, Zhao S, Song X. Tumor-derived exosomal miRNAs as diagnostic biomarkers in non-small cell lung cancer. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.560025.","DOI":"10.3389\/fonc.2020.560025"},{"key":"1505_CR179","doi-asserted-by":"crossref","unstructured":"Zhang ZJ, Song XG, Xie L, Wang KY, Tang YY, Yu M. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early- stage non-small cell lung cancer. Exp Biol Med. 2020;245:10.","DOI":"10.1177\/1535370220945987"},{"key":"1505_CR180","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3389\/fgene.2020.00258","volume":"11","author":"C Liu","year":"2020","unstructured":"Liu C, Kannisto E, Yu G, Yang Y, Reid ME, Patnaik SK. Non-invasive detection of exosomal MicroRNAs via tethered cationic lipoplex nanoparticles (tCLN) biochip for lung cancer early detection. Front Genet. 2020;11:258.","journal-title":"Front Genet"},{"key":"1505_CR181","doi-asserted-by":"publisher","first-page":"e0167706","DOI":"10.1371\/journal.pone.0167706","volume":"11","author":"X Lai","year":"2016","unstructured":"Lai X, Friedman A. Exosomal miRs in lung cancer: a mathematical model. PLoS One. 2016;11:e0167706.","journal-title":"PLoS One"},{"key":"1505_CR182","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2147\/CMAR.S232383","volume":"12","author":"Q Wu","year":"2020","unstructured":"Wu Q, Yu L, Lin X, Zheng Q, Zhang S, Chen D. Combination of serum miRNAs with serum exosomal miRNAs in early diagnosis for non-small-cell lung cancer. Cancer Manag Res. 2020;12:485\u201395.","journal-title":"Cancer Manag Res"},{"key":"1505_CR183","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10585-020-10062-y","volume":"38","author":"XR Yang","year":"2021","unstructured":"Yang XR, Pi C, Yu R, Fan XJ, Peng ZXX. X.C. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer. Clin Exp Metastasis. 2021;38:109\u201317.","journal-title":"Clin Exp Metastasis"},{"key":"1505_CR184","doi-asserted-by":"crossref","unstructured":"Xiong H, Lu M, Wu F. Exosomal microRNA-214 expression and its prognostic significance in non-small cell lung cancer patients. J King Saud Univ Sci. 2020.","DOI":"10.1016\/j.jksus.2019.10.001"},{"key":"1505_CR185","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1158\/1055-9965.EPI-18-0569","volume":"28","author":"D Yuwen","year":"2019","unstructured":"Yuwen D, Ma Y, Wang D. Prognostic role of circulating exosomal miR-425-3p for the response of NSCLC to platinum-based chemotherapy. Cancer Epidemiol Biomark Prev. 2019;28:163\u201373.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1505_CR186","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.70554","volume":"15","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Ma H, Zheng Y, Wang L, Wang C, Liu Y, et al. Exosomal miR-3126-5p derived from cancer-associated fibroblasts facilitates glycolysis to accelerate NSCLC progression by targeting KLF13 to activate the SH2B1\/IRS1 axis. Clin Transl Med. 2025;15:e70554.","journal-title":"Clin Transl Med"},{"key":"1505_CR187","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41417-020-00216-1","volume":"28","author":"S Xu","year":"2020","unstructured":"Xu S, Zheng L, Kang L, Xu H, Gao L. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2\/LSD1\/ CDH1-dependent manner. Cancer Gene Ther. 2020;28:250\u201364.","journal-title":"Cancer Gene Ther"},{"key":"1505_CR188","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-021-02075-8","volume":"21","author":"X Li","year":"2021","unstructured":"Li X, Chen C, Wang Z, Liu J, Sun W, Shen K. Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer. Cancer Cell Int. 2021;21:1\u201314.","journal-title":"Cancer Cell Int"},{"key":"1505_CR189","doi-asserted-by":"publisher","DOI":"10.1080\/15476278.2025.2575590","volume":"21","author":"C Su","year":"2025","unstructured":"Su C, Han X, Zhang K. Exosomal miR-29a-3p derived from bone marrow stromal cells suppresses malignant behavior of NSCLC by regulating DNMT3A\/JAK2\/STAT3 axis. Organogenesis. 2025;21:2575590.","journal-title":"Organogenesis"},{"key":"1505_CR190","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.989","volume":"12","author":"L Shi","year":"2022","unstructured":"Shi L, Zhu W, Huang Y, Zhuo L, Wang S, Chen S, et al. Cancer-associated fibroblast-derived exosomal microRNA-20a suppresses the PTEN\/PI3K-AKT pathway to promote the progression and chemoresistance of non-small cell lung cancer. Clin Transl Med. 2022;12:e989.","journal-title":"Clin Transl Med"},{"key":"1505_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jcla.23743","volume":"35","author":"J Xia","year":"2021","unstructured":"Xia J, Luo M, Dai L, Wang L, Wang L, Zhu J. Serum exosomal microRNAs as predictive markers for EGFR mutations in non\u2013small-cell lung cancer. J Clin Lab Anal. 2021;35:1\u201312.","journal-title":"J Clin Lab Anal"},{"key":"1505_CR192","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.sjbs.2021.01.013","volume":"28","author":"T Wang","year":"2021","unstructured":"Wang T, Li W, Li H, Li W. Dysregulation of exosomal miR-192 and miR-194 expression in lung adenocarcinoma patients. Saudi J Biol Sci. 2021;28:1561\u20138.","journal-title":"Saudi J Biol Sci"},{"key":"1505_CR193","doi-asserted-by":"crossref","unstructured":"Zheng B, Peng M, Gong J, Li C, Cheng H, Li Y. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer. Exp Biol Med. 2023;248:1403\u201313.","DOI":"10.1177\/15353702231184223"},{"key":"1505_CR194","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/cells13181562","volume":"13","author":"AAI Hassanin","year":"2024","unstructured":"Hassanin AAI, Ramos KS. Circulating exosomal miRNA profiles in non-small cell lung cancers. Cells. 2024;13:1562.","journal-title":"Cells"},{"key":"1505_CR195","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12523-z","volume":"24","author":"W Yan","year":"2024","unstructured":"Yan W, Yang H, Duan D, Wu Y, Liu Y, Mao J, et al. Bone marrow mesenchymal stem cells-derived exosomal miR-145-5p reduced non-small cell lung cancer cell progression by targeting SOX9. BMC Cancer. 2024;24:883.","journal-title":"BMC Cancer"},{"key":"1505_CR196","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2023.147177","volume":"857","author":"K Hisakane","year":"2023","unstructured":"Hisakane K, Seike M, Sugano T, Matsuda K, Kashiwada T, Nakamichi S, et al. Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1\/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer. Gene. 2023;857:147177.","journal-title":"Gene"},{"key":"1505_CR197","doi-asserted-by":"crossref","unstructured":"Peng XX, Yu R, Wu X, Wu SY, Pi C, Chen ZH et al. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR\/ALK wild-type advanced non-small cell lung cancer. J Immunother Cancer. 2020;8:1\u20137.","DOI":"10.1136\/jitc-2019-000376"},{"key":"1505_CR198","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.molimm.2024.08.001","volume":"174","author":"B Liu","year":"2024","unstructured":"Liu B, Rui Y, Li M, Huang L. Cancer cell-derived exosomes promote NSCLC progression via the miR-199b-5p\/HIF1AN axis. Mol Immunol. 2024;174:32\u201340.","journal-title":"Mol Immunol"},{"key":"1505_CR199","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.70080","volume":"38","author":"H Ma","year":"2024","unstructured":"Ma H, Jiang B, Ren Q, Sun Y, Wang M, Xia S, et al. Exosomal miR-20b-5p induces EMT and enhances progression in non-small cell lung cancer via TGFBR2 downregulation. J Biochem Mol Toxicol. 2024;38:e70080.","journal-title":"J Biochem Mol Toxicol"},{"key":"1505_CR200","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155271","volume":"256","author":"H Sun","year":"2024","unstructured":"Sun H, Zhu R, Guo X, Zhao P, Zhang R, Zhao Z, et al. Exosome miR-101-3p derived from bone marrow mesenchymal stem cells promotes radiotherapy sensitivity in non-small cell lung cancer by regulating DNA damage repair and autophagy levels through EZH2. Pathol Res Pract. 2024;256:155271.","journal-title":"Pathol Res Pract"},{"key":"1505_CR201","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1007\/s13577-022-00766-6","volume":"35","author":"J Liu","year":"2022","unstructured":"Liu J, Cao L, Li Y, Deng P, Pan P, Hu C, et al. Pirfenidone promotes the levels of exosomal miR-200 to down-regulate ZEB1 and represses the epithelial-mesenchymal transition of non-small cell lung cancer cells. Hum Cell. 2022;35:1813\u201323.","journal-title":"Hum Cell"},{"key":"1505_CR202","first-page":"469","volume":"14","author":"R Luo","year":"2021","unstructured":"Luo R, Liu H, Chen J. Reduced circulating exosomal miR-382 predicts unfavorable outcome in non-small cell lung cancer. Int J Clin Exp Pathol. 2021;14:469\u201374.","journal-title":"Int J Clin Exp Pathol"},{"key":"1505_CR203","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.2147\/OTT.S263934","volume":"13","author":"Y Wu","year":"2020","unstructured":"Wu Y, Wei J, Zhang W, Xie M, Wang X, Xu J. Serum exosomal miR-1290 is a potential biomarker for lung adenocarcinoma. Onco Targets Ther. 2020;13:7809\u201318.","journal-title":"Onco Targets Ther"},{"key":"1505_CR204","doi-asserted-by":"publisher","unstructured":"Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A. A circulating risk score, based on combined expression of exo-miR-130a-3p and fibrinopeptide A. 2022:14. https:\/\/doi.org\/10.3390\/cancers14143412.","DOI":"10.3390\/cancers14143412"},{"key":"1505_CR205","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.1080\/21655979.2022.2036891","volume":"13","author":"H Lv","year":"2022","unstructured":"Lv H, Yu J, Zhang H, Qian X, Wang Q, Lu B, et al. MicroRNA-631 deriving from bone marrow mesenchymal stem cell exosomes facilitates the malignant behavior of non-small cell lung cancer via modulating the E2F family of transcription factor 2\/phosphatidylinositol 3-kinase\/Akt signaling pathway. Bioengineered. 2022;13:8382\u201395.","journal-title":"Bioengineered"},{"key":"1505_CR206","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ol.2021.12868","volume":"22","author":"B Liu","year":"2021","unstructured":"Liu B, Zhang R, Zhu Y, Hao R. Exosome-derived microRNA-433 inhibits tumorigenesis through incremental infiltration of CD4 and CD8 cells in non-small cell lung cancer. Oncol Lett. 2021;22:1\u201312.","journal-title":"Oncol Lett"},{"key":"1505_CR207","first-page":"2165","volume":"44","author":"X Zhao","year":"2020","unstructured":"Zhao X, Li M, Dai X, Yang Y, Peng Y, Xu C. Downregulation of exosomal miR-1273a increases cisplatin resistance of non-small cell lung cancer by upregulating the expression of syndecan binding protein. Oncol Rep. 2020;44:2165\u201373.","journal-title":"Oncol Rep"},{"key":"1505_CR208","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/jcm11030655","volume":"11","author":"K Baran","year":"2022","unstructured":"Baran K, Kordiak J, Jab\u0142o\u0144ski S, Antczak A, Brzezia\u0144ska-Lasota E. The significance of the alter miR let-7a and miR-335 expression levels regulating the CCR7\/CCL19 axis as potential biomarkers of tumor progression in NSCLC. J Clin Med. 2022;11:655.","journal-title":"J Clin Med"},{"key":"1505_CR209","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105442","volume":"165","author":"R Chen","year":"2021","unstructured":"Chen R, Qian Z, Xu X, Zhang C, Niu Y, Wang Z. Exosomes-transmitted miR-7 reverses gefitinib resistance by targeting YAP in non-small-cell lung cancer. Pharm Res. 2021;165:105442.","journal-title":"Pharm Res"},{"key":"1505_CR210","first-page":"4655","volume":"16","author":"L Yan","year":"2018","unstructured":"Yan L, Ma J, Wang Y, Zan J, Wang Z, Zhu Y, et al. miR-21-5p induces cell proliferation by targeting TGFBI in non-small cell lung cancer cells. Exp Ther Med. 2018;16:4655\u201363.","journal-title":"Exp Ther Med"},{"key":"1505_CR211","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.2147\/OTT.S172393","volume":"11","author":"X Li","year":"2018","unstructured":"Li X, Wu X. MiR-21-5p promotes the progression of non-small-cell lung cancer by regulating the expression of SMAD7. Onco Targets Ther. 2018;11:8445\u201354.","journal-title":"Onco Targets Ther"},{"key":"1505_CR212","doi-asserted-by":"publisher","first-page":"5402","DOI":"10.1158\/0008-5472.CAN-13-0297","volume":"73","author":"J Cai","year":"2013","unstructured":"Cai J, Fang L, Huang Y, Li R, Yuan J, Yang Y, et al. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. Cancer Res. 2013;73:5402\u201315.","journal-title":"Cancer Res"},{"key":"1505_CR213","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3892\/or.2013.2755","volume":"30","author":"L Lei","year":"2013","unstructured":"Lei L, Huang Y, Gong W. miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTEN. Oncol Rep. 2013;30:2897\u2013902.","journal-title":"Oncol Rep"},{"key":"1505_CR214","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/bjc.2013.761","volume":"110","author":"L Larzabal","year":"2014","unstructured":"Larzabal L, de Aberasturi AL, Redrado M, Rueda P, Rodriguez MJ, Bodegas ME, et al. TMPRSS4 regulates levels of integrin \u03b15 in NSCLC through miR-205 activity to promote metastasis. Br J Cancer. 2014;110:3","journal-title":"Br J Cancer"},{"key":"1505_CR215","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11010-013-1755-y","volume":"383","author":"M Jiang","year":"2013","unstructured":"Jiang M, Zhang P, Hu G, Xiao Z, Xu F, Zhong T, et al. Relative expressions of miR-205-5p, miR-205-3p, and miR-21 in tissues and serum of non-small cell lung cancer patients. Mol Cell Biochem. 2013;383:67\u201375.","journal-title":"Mol Cell Biochem"},{"key":"1505_CR216","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev-pathol-012513-104715","volume":"9","author":"G Di Leva","year":"2014","unstructured":"Di Leva G, Garofalo M, Croce CM. microRNAs in cancer. Annu Rev Pathol. 2014;9:287\u2013314.","journal-title":"Annu Rev Pathol"},{"key":"1505_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.663279","volume":"9","author":"Y Guo","year":"2021","unstructured":"Guo Y, Wang G, Wang Z, Ding X, Qian L, Li Y, et al. Reck-Notch1 Signaling mediates miR-221\/222 regulation of lung cancer stem cells in NSCLC. Front Cell Dev Biol. 2021;9:663279.","journal-title":"Front Cell Dev Biol"},{"key":"1505_CR218","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0694-8","volume":"16","author":"F Wei","year":"2017","unstructured":"Wei F, Ma C, Zhou T, Dong X, Luo Q, Geng L, et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol Cancer. 2017;16:132.","journal-title":"Mol Cancer"},{"key":"1505_CR219","doi-asserted-by":"publisher","first-page":"8121","DOI":"10.1007\/s13277-015-3550-8","volume":"36","author":"L Zhang","year":"2015","unstructured":"Zhang L, Quan H, Wang S, Li X, Che X. MiR-183 promotes growth of non-small cell lung cancer cells through FoxO1 inhibition. Tumour Biol. 2015;36:8121\u20136.","journal-title":"Tumour Biol"},{"key":"1505_CR220","doi-asserted-by":"publisher","first-page":"e0153046","DOI":"10.1371\/journal.pone.0153046","volume":"11","author":"W Zhu","year":"2016","unstructured":"Zhu W, Zhou K, Zha Y, Chen D, He J, Ma H, et al. Diagnostic value of serum miR-182, miR-183, miR-210, and miR-126 levels in patients with early-stage non-small cell lung cancer. PLoS ONE. 2016;11:e0153046.","journal-title":"PLoS ONE"},{"key":"1505_CR221","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1016\/j.febslet.2008.09.051","volume":"582","author":"G Wang","year":"2008","unstructured":"Wang G, Mao W, Zheng S. MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett. 2008;582:3663\u20138.","journal-title":"FEBS Lett"},{"key":"1505_CR222","doi-asserted-by":"publisher","unstructured":"M K, Es L, G H, YK. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem. 2008;283. https:\/\/doi.org\/10.1074\/jbc.C800074200.","DOI":"10.1074\/jbc.C800074200"},{"key":"1505_CR223","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.biopha.2010.01.018","volume":"64","author":"W Gao","year":"2010","unstructured":"Gao W, Yu Y, Cao H, Shen H, Li X, Pan S, et al. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother. 2010;64:399\u2013408.","journal-title":"Biomed Pharmacother"},{"key":"1505_CR224","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1093\/abbs\/gmv054","volume":"47","author":"Z Ma","year":"2015","unstructured":"Ma Z, Qiu X, Wang D, Li Y, Zhang B, Yuan T, et al. MiR-181a-5p inhibits cell proliferation and migration by targeting Kras in non-small cell lung cancer A549 cells. Acta Biochim Biophys Sin. 2015;47:630\u20138.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1505_CR225","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1007\/s13277-014-2972-z","volume":"36","author":"P Huang","year":"2015","unstructured":"Huang P, Ye B, Yang Y, Shi J, Zhao H. MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2. Tumour Biol. 2015;36:3381\u20137.","journal-title":"Tumour Biol"},{"key":"1505_CR226","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3233\/CBM-170350","volume":"20","author":"Q Shi","year":"2017","unstructured":"Shi Q, Zhou Z, Ye N, Chen Q, Zheng X, Fang M. MiR-181a inhibits non-small cell lung cancer cell proliferation by targeting CDK1. Cancer Biomark. 2017;20:539\u201346.","journal-title":"Cancer Biomark"},{"key":"1505_CR227","first-page":"3391","volume":"8","author":"Y Luan","year":"2015","unstructured":"Luan Y, Zhang S, Zuo L, Zhou L. Overexpression of miR-100 inhibits cell proliferation, migration, and chemosensitivity in human glioblastoma through FGFR3. OncoTargets Ther. 2015;8:3391.","journal-title":"OncoTargets Ther"},{"key":"1505_CR228","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1111\/1759-7714.13459","volume":"11","author":"W Han","year":"2020","unstructured":"Han W, Ren X, Yang Y, Li H, Zhao L, Lin Z. microRNA-100 functions as a tumor suppressor in non-small cell lung cancer via regulating epithelial-mesenchymal transition and Wnt\/\u03b2-catenin by targeting HOXA1. Thorac Cancer. 2020;11:1679\u201388.","journal-title":"Thorac Cancer"},{"key":"1505_CR229","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.canlet.2011.11.024","volume":"317","author":"B Feng","year":"2012","unstructured":"Feng B, Wang R, Chen LB. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1. Cancer Lett. 2012;317:184\u201391.","journal-title":"Cancer Lett"},{"key":"1505_CR230","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/cdd.2010.119","volume":"18","author":"MP Puiss\u00e9gur","year":"2011","unstructured":"Puiss\u00e9gur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, et al. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 2011;18:465\u201378.","journal-title":"Cell Death Differ"},{"key":"1505_CR231","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109675","volume":"73","author":"F Yang","year":"2020","unstructured":"Yang F, Yan Y, Yang Y, Hong X, Wang M, Yang Z, et al. MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN\/PI3K\/AKT pathway. Cell Signal. 2020;73:109675.","journal-title":"Cell Signal"},{"key":"1505_CR232","doi-asserted-by":"publisher","first-page":"688","DOI":"10.3389\/fgene.2019.00688","volume":"10","author":"F Tian","year":"2019","unstructured":"Tian F, Wang J, Ouyang T, Lu N, Lu J, Shen Y, et al. MiR-486-5p serves as a good biomarker in nonsmall cell lung cancer and suppresses cell growth with the involvement of a target PIK3R1. Front Genet. 2019;10:688.","journal-title":"Front Genet"},{"key":"1505_CR233","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.655236","volume":"11","author":"L Ding","year":"2021","unstructured":"Ding L, Tian W, Zhang H, Li W, Ji C, Wang Y, et al. MicroRNA-486-5p suppresses lung cancer via downregulating mTOR signaling in vitro and in vivo. Front Oncol. 2021;11:655236.","journal-title":"Front Oncol"},{"key":"1505_CR234","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.lungcan.2009.01.010","volume":"66","author":"B Liu","year":"2009","unstructured":"Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer. 2009;66:169\u201375.","journal-title":"Lung Cancer"},{"key":"1505_CR235","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.cllc.2016.03.012","volume":"17","author":"L Song","year":"2016","unstructured":"Song L, Li D, Gu Y, Wen ZM, Jie J, Zhao D, et al. MicroRNA-126 targeting PIK3R2 inhibits NSCLC A549 cell proliferation, migration, and invasion by regulation of PTEN\/PI3K\/AKT pathway. Clin Lung Cancer. 2016;17:e65\u201375.","journal-title":"Clin Lung Cancer"},{"key":"1505_CR236","doi-asserted-by":"publisher","first-page":"e42978","DOI":"10.1371\/journal.pone.0042978","volume":"7","author":"J Yang","year":"2012","unstructured":"Yang J, Lan H, Huang X, Liu B, Tong Y. MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients. PLoS ONE. 2012;7:e42978.","journal-title":"PLoS ONE"},{"key":"1505_CR237","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1093\/abbs\/gms026","volume":"44","author":"X Zhu","year":"2012","unstructured":"Zhu X, Li H, Long L, Hui L, Chen H, Wang X, et al. miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A. Acta Biochim Biophys Sin. 2012;44:519\u201326.","journal-title":"Acta Biochim Biophys Sin"},{"key":"1505_CR238","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.bbrc.2008.06.090","volume":"373","author":"M Crawford","year":"2008","unstructured":"Crawford M, Brawner E, Batte K, Yu L, Hunter MG, Otterson GA, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun. 2008;373:607\u201312.","journal-title":"Biochem Biophys Res Commun"},{"key":"1505_CR239","doi-asserted-by":"publisher","first-page":"37524","DOI":"10.18632\/oncotarget.6852","volume":"7","author":"Z Ye","year":"2016","unstructured":"Ye Z, Yin S, Su Z, Bai M, Zhang H, Hei Z, et al. Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2. Oncotarget. 2016;7:37524\u201335.","journal-title":"Oncotarget"},{"key":"1505_CR240","doi-asserted-by":"publisher","first-page":"8435","DOI":"10.1080\/21655979.2021.1982274","volume":"12","author":"D Cui","year":"2021","unstructured":"Cui D, Feng Y, Qian R. Up-regulation of microRNA miR-101-3p enhances sensitivity to cisplatin via regulation of small interfering RNA (siRNA) Anti-human AGT4D and autophagy in non-small-cell lung carcinoma (NSCLC). Bioengineered. 2021;12:8435\u201346.","journal-title":"Bioengineered"},{"key":"1505_CR241","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.biopha.2017.07.005","volume":"93","author":"X Zhang","year":"2017","unstructured":"Zhang X, He X, Liu Y, Zhang H, Chen H, Guo S, et al. MiR-101-3p inhibits the growth and metastasis of non-small cell lung cancer through blocking PI3K\/AKT signal pathway by targeting MALAT-1. Biomed Pharmacother. 2017;93:1065\u201373.","journal-title":"Biomed Pharmacother"},{"key":"1505_CR242","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1097\/JTO.0b013e318208eb35","volume":"6","author":"JG Zhang","year":"2011","unstructured":"Zhang JG, Guo JF, Liu DL, Liu Q, Wang JJ. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. J Thorac Oncol. 2011;6:671\u20138.","journal-title":"J Thorac Oncol"},{"key":"1505_CR243","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12033-014-9796-3","volume":"57","author":"P Yin","year":"2015","unstructured":"Yin P, Peng R, Peng H, Yao L, Sun Y, Wen L, et al. MiR-451 suppresses cell proliferation and metastasis in A549 lung cancer cells. Mol Biotechnol. 2015;57:1\u201311.","journal-title":"Mol Biotechnol"},{"key":"1505_CR244","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1038\/onc.2010.642","volume":"30","author":"R Wang","year":"2011","unstructured":"Wang R, Wang ZX, Yang JS, Pan X, De W, Chen LB. MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 2011;30:2644\u201358.","journal-title":"Oncogene"},{"key":"1505_CR245","doi-asserted-by":"publisher","first-page":"23227","DOI":"10.1074\/jbc.M112.373084","volume":"287","author":"R Fang","year":"2012","unstructured":"Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, et al. MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem. 2012;287:23227\u201335.","journal-title":"J Biol Chem"},{"key":"1505_CR246","doi-asserted-by":"publisher","first-page":"11973","DOI":"10.3390\/ijms150711973","volume":"15","author":"H Xia","year":"2014","unstructured":"Xia H, Sun S, Wang B, Wang T, Liang C, Li G, et al. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. Int J Mol Sci. 2014;15:11973.","journal-title":"Int J Mol Sci"},{"key":"1505_CR247","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3892\/mmr.2014.2675","volume":"11","author":"J Wei","year":"2015","unstructured":"Wei J, Ma Z, Li Y, Zhao B, Wang D, Jin Y, et al. miR\u2011143 inhibits cell proliferation by targeting autophagy\u2011related 2B in non\u2011small cell lung cancer H1299 cells. Mol Med Rep. 2015;11:571\u20136.","journal-title":"Mol Med Rep"},{"key":"1505_CR248","doi-asserted-by":"publisher","first-page":"10022","DOI":"10.3390\/ijms241210022","volume":"24","author":"WC Cho","year":"2023","unstructured":"Cho WC, Wong CF, Li KP, Fong AH, Fung KY, Au JS. miR-145 as a potential biomarker and therapeutic target in patients with non-small cell lung cancer. Int J Mol Sci. 2023;24:10022.","journal-title":"Int J Mol Sci"},{"key":"1505_CR249","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1089\/dna.2020.5415","volume":"39","author":"J Li","year":"2020","unstructured":"Li J, Song Y, Yu B, Yu Y. TNFAIP2 promotes non-small cell lung cancer cells and targeted by miR-145-5p. DNA Cell Biol. 2020;39:1256\u201363.","journal-title":"DNA Cell Biol"},{"key":"1505_CR250","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.canlet.2013.09.034","volume":"343","author":"Z Dong","year":"2014","unstructured":"Dong Z, Zhong Z, Yang L, Wang S, Gong Z. MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Lett. 2014;343:249\u201357.","journal-title":"Cancer Lett"},{"key":"1505_CR251","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s13277-013-0741-z","volume":"34","author":"Z Zhong","year":"2013","unstructured":"Zhong Z, Dong Z, Yang L, Chen X, Gong Z. MicroRNA-31-5p modulates cell cycle by targeting human mutL homolog 1 in human cancer cells. Tumour Biol. 2013;34:1959\u201365.","journal-title":"Tumour Biol"},{"key":"1505_CR252","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-67908-4","volume":"10","author":"XF Li","year":"2020","unstructured":"Li XF, Shen WZ, Jin X, Ren P, Zhang J. Let-7c regulated epithelial-mesenchymal transition leads to osimertinib resistance in NSCLC cells with EGFR T790M mutations. Sci Rep. 2020;10:11236.","journal-title":"Sci Rep"},{"key":"1505_CR253","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.canlet.2013.08.030","volume":"342","author":"B Zhao","year":"2014","unstructured":"Zhao B, Han H, Chen J, Zhang Z, Li S, Fang F, et al. MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett. 2014;342:43\u201351.","journal-title":"Cancer Lett"},{"key":"1505_CR254","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13277-013-1004-8","volume":"35","author":"M Wang","year":"2014","unstructured":"Wang M, Wang Y, Zang W, Wang H, Chu H, Li P, et al. Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. Tumour Biol. 2014;35:39\u201346.","journal-title":"Tumour Biol"},{"key":"1505_CR255","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.bbrc.2010.04.127","volume":"396","author":"Y Sun","year":"2010","unstructured":"Sun Y, Fang R, Li C, Li L, Li F, Ye X, et al. Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochem Biophys Res Commun. 2010;396:501\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1505_CR256","doi-asserted-by":"publisher","first-page":"E4288","DOI":"10.1073\/pnas.1502068112","volume":"112","author":"R Cui","year":"2015","unstructured":"Cui R, Meng W, Sun HL, Kim T, Ye Z, Fassan M, et al. MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci USA. 2015;112:E4288\u20134297.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1505_CR257","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/nature05939","volume":"447","author":"L He","year":"2007","unstructured":"He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130\u20134.","journal-title":"Nature"},{"key":"1505_CR258","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","volume":"26","author":"N Raver-Shapira","year":"2007","unstructured":"Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007;26:731\u201343.","journal-title":"Mol Cell"},{"key":"1505_CR259","doi-asserted-by":"publisher","first-page":"djv303","DOI":"10.1093\/jnci\/djv303","volume":"108","author":"MA Cortez","year":"2016","unstructured":"Cortez MA, Ivan C, Valdecanas D, Wang X, Peltier HJ, Ye Y, et al. PDL1 Regulation by p53 via miR-34. J Natl Cancer Inst. 2016;108:djv303.","journal-title":"J Natl Cancer Inst"},{"key":"1505_CR260","doi-asserted-by":"publisher","first-page":"13149","DOI":"10.18632\/oncotarget.3693","volume":"6","author":"Z Han","year":"2015","unstructured":"Han Z, Zhang Y, Yang Q, Liu B, Wu J, Zhang Y, et al. miR-497 and miR-34a retard lung cancer growth by co-inhibiting cyclin E1 (CCNE1). Oncotarget. 2015;6:13149.","journal-title":"Oncotarget"},{"key":"1505_CR261","first-page":"1135","volume":"11","author":"L Ruan","year":"2018","unstructured":"Ruan L, Chen J, Ruan L, Tan A, Wang P. miR-34a inhibits tumorigenesis of NSCLC via targeting SIRT6. Int J Clin Exp Pathol. 2018;11:1135\u201345.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01505-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01505-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:02:53Z","timestamp":1787029373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-026-01505-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":261,"alternative-id":["1505"],"URL":"https:\/\/doi.org\/10.1038\/s10038-026-01505-7","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}